Found: 55
Select item for more details and to access through your institution.
Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 11, p. 1507, doi. 10.1513/AnnalsATS.202404-366OC
- By:
- Publication type:
- Article
Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 10, p. 2398, doi. 10.1093/jac/dkr303
- By:
- Publication type:
- Article
Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 5, p. 879, doi. 10.1093/jac/dki338
- By:
- Publication type:
- Article
Home Self-Collection of Nasal Swabs for Diagnosis of Acute Respiratory Virus Infections in Children With Cystic Fibrosis.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2013, v. 2, n. 4, p. 345, doi. 10.1093/jpids/pit039
- By:
- Publication type:
- Article
Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
- Published in:
- Annals of the American Thoracic Society, 2023, v. 20, n. 1, p. 75, doi. 10.1513/AnnalsATS.202203-201OC
- By:
- Publication type:
- Article
Clinical Outcomes of Antipseudomonal versus Other Antibiotics among Children with Cystic Fibrosis without .
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association of Inhaled Antibiotics in Addition to Standard Intravenous Therapy and Outcomes of Pediatric Inpatient Pulmonary Exacerbations.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Longitudinal Assessment of Pseudomonas aeruginosa in Young Children with Cystic Fibrosis.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 3, p. 444, doi. 10.1086/318075
- By:
- Publication type:
- Article
Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
- Published in:
- Nature Genetics, 2012, v. 44, n. 8, p. 886, doi. 10.1038/ng.2344
- By:
- Publication type:
- Article
Effect of extending the time after bronchodilator administration on identifying bronchodilator responsiveness in a pediatric pulmonary clinic.
- Published in:
- Pediatric Pulmonology, 2017, v. 52, n. 8, p. 984, doi. 10.1002/ppul.23752
- By:
- Publication type:
- Article
Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.
- Published in:
- Pediatric Pulmonology, 2015, v. 50, n. 8, p. 763, doi. 10.1002/ppul.23217
- By:
- Publication type:
- Article
Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2015, v. 50, n. 1, p. 42, doi. 10.1002/ppul.23036
- By:
- Publication type:
- Article
Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2013, v. 48, n. 10, p. 943, doi. 10.1002/ppul.22693
- By:
- Publication type:
- Article
Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2012, v. 47, n. 2, p. 125, doi. 10.1002/ppul.21525
- By:
- Publication type:
- Article
Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection.
- Published in:
- Pediatric Pulmonology, 2011, v. 46, n. 2, p. 184, doi. 10.1002/ppul.21350
- By:
- Publication type:
- Article
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2010, v. 45, n. 11, p. 1121, doi. 10.1002/ppul.21301
- By:
- Publication type:
- Article
Baseline Characteristics and Factors Associated With Nutritional and Pulmonary Status at Enrollment in the Cystic Fibrosis EPIC Observational Cohort.
- Published in:
- Pediatric Pulmonology, 2010, v. 45, n. 9, p. 934, doi. 10.1002/ppul.21279
- By:
- Publication type:
- Article
Return of FEV<sub>1</sub> after pulmonary exacerbation in children with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2010, v. 45, n. 5, p. 521, doi. 10.1002/ppul.21249
- By:
- Publication type:
- Article
Return of FEV<sub>1</sub> after pulmonary exacerbation in children with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2010, v. 45, n. 2, p. 127, doi. 10.1002/ppul.21117
- By:
- Publication type:
- Article
A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.
- Published in:
- Pediatric Pulmonology, 2008, v. 43, n. 1, p. 47, doi. 10.1002/ppul.20736
- By:
- Publication type:
- Article
Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2007, v. 42, n. 7, p. 610, doi. 10.1002/ppul.20625
- By:
- Publication type:
- Article
Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosisSome of the results of this study were previously reported at the North American Cystic Fibrosis Conference in October 2004.
- Published in:
- Pediatric Pulmonology, 2006, v. 41, n. 7, p. 656, doi. 10.1002/ppul.20429
- By:
- Publication type:
- Article
Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study of Aerosolized Interferon Gamma-1b in Patients With Mild to Moderate Cystic Fibrosis Lung DiseaseOur results were presented in part at the American Thoracic Society 2003 Annual Meeting (Moss et al., Am J Respir Crit Care Med 2003;167:923).Conflict of interest statement: Karen Starko, M.D., is an employee of Intermune, Inc., which partly sponsored this study, provided study agents, and participated in data analysis.
- Published in:
- Pediatric Pulmonology, 2005, v. 39, n. 3, p. 209, doi. 10.1002/ppul.20152
- By:
- Publication type:
- Article
Plastic bronchitis in children: A case series and review of the medical literature.
- Published in:
- Pediatric Pulmonology, 2002, v. 34, n. 6, p. 482, doi. 10.1002/ppul.10179
- By:
- Publication type:
- Article
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2002, v. 34, n. 2, p. 91, doi. 10.1002/ppul.10127
- By:
- Publication type:
- Article
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2001, v. 32, n. 5, p. 356, doi. 10.1002/ppul.1144
- By:
- Publication type:
- Article
Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment.
- Published in:
- 2005
- By:
- Publication type:
- journal article
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One Allele.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cystic Fibrosis Lung Function Decline after Within-Host Evolution Increases Virulence of Infecting Pseudomonas aeruginosa.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of amrinone during group B Strepfococcus-induced pulmonary hypertension in piglets.
- Published in:
- Pediatric Pulmonology, 1993, v. 16, n. 5, p. 303, doi. 10.1002/ppul.1950160506
- By:
- Publication type:
- Article
Respiratory mechanics of the piglet during the first month of life.
- Published in:
- Pediatric Pulmonology, 1991, v. 11, n. 4, p. 294, doi. 10.1002/ppul.1950110405
- By:
- Publication type:
- Article
Inflammasome Genetic Variants, Macrophage Function, and Clinical Outcomes in Cystic Fibrosis.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2021, v. 65, n. 2, p. 157, doi. 10.1165/rcmb.2020-0257OC
- By:
- Publication type:
- Article
Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. 1589, doi. 10.1093/cid/ciab525
- By:
- Publication type:
- Article
Association of Intensity of Antipseudomonal Antibiotic Therapy With Risk of Treatment-Emergent Organisms in Children With Cystic Fibrosis and Newly Acquired Pseudomonas Aeruginosa.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 6, p. 987, doi. 10.1093/cid/ciab208
- By:
- Publication type:
- Article
Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 5, p. 707, doi. 10.1093/cid/civ377
- By:
- Publication type:
- Article
Pseudomonas aeruginosa Phenotypes Associated With Eradication Failure in Children With Cystic Fibrosis.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 5, p. 624, doi. 10.1093/cid/ciu385
- By:
- Publication type:
- Article
Staphylococcus aureus Small-Colony Variants Are Independently Associated With Worse Lung Disease in Children With Cystic Fibrosis.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 3, p. 384, doi. 10.1093/cid/cit270
- By:
- Publication type:
- Article
Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Pseudomonas aeruginosa In Vitro Phenotypes Distinguish Cystic Fibrosis Infection Stages and Outcomes.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2014, v. 190, n. 3, p. 289, doi. 10.1164/rccm.201404-0681oc
- By:
- Publication type:
- Article
Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2003, v. 168, n. 12, p. 1471, doi. 10.1164/rccm.200306-731OC
- By:
- Publication type:
- Article
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2003, v. 168, n. 8, p. 918, doi. 10.1164/rccm.200304-505SO
- By:
- Publication type:
- Article
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2003, v. 167, n. 6, p. 841, doi. 10.1164/rccm.200208-855OC
- By:
- Publication type:
- Article
Sinonasal Quality of Life in Children With Cystic Fibrosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings.
- Published in:
- Influenza & Other Respiratory Viruses, 2012, v. 6, n. 3, p. 218, doi. 10.1111/j.1750-2659.2011.00292.x
- By:
- Publication type:
- Article
Correction: Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
- Published in:
- 2015
- By:
- Publication type:
- Correction Notice
Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
- Published in:
- PLoS Genetics, 2015, v. 11, n. 6, p. 1, doi. 10.1371/journal.pgen.1005273
- By:
- Publication type:
- Article
Chronic Azithromycin Use in Cystic Fibrosis and Risk of Treatment-Emergent Respiratory Pathogens.
- Published in:
- 2018
- By:
- Publication type:
- journal article